So Pantone® has chosen its colour of the year for 2019.
It’s handily entitled Pantone 16-1546, but to you and me it’s been named ‘Living Coral’.
They say (it’s)…’an animating and life-affirming coral hue with a golden undertone that energizes and enlivens with a softer edge’.
A softer edge that what you may ask? I’ll leave that to you to decide whether there was ‘political thinking’ involved?
However, for me, with our natural planet under so much threat, it’s interesting to see Pantone® and other early, indicative ‘design’ trends openly nudging today’s designers and creators to return to a more primal simple colour signpost to provide a visual inspiration to the very digital world we live in.
Expect to see this colour and creative thinking in a lot of studio outputs in 2019.
Pick of this week’s AI media coverage came in the shape of a thought-provoking report by Katyanna Quach at The Register, reporting on a keynote speech at the NeurIPS conference by Michael Levin professor and director of the Allen Discovery Centre at Tufts University. “Intelligent behaviour doesn’t require a brain,” her sub-head teased as a lead-in, before an exploration of how artificial intelligence computing innovation can be inspired by biological systems beyond simply the human brain.
As well as the technical advantages Levin discusses, broadening the definition of AI beyond a slavish replication of the human brain’s functionality can have advantages for setting the right context for development. Broadening the discussions may also alleviate the perhaps unhelpful association the public has with AI as a replication (and thus, potentially a replacement), for human thinking.
£1.3bn industry/government partnership to apply AI to early disease detection
The government has announced a £1.3bm partnership with the life sciences industry to accelerate detection of disease using AI. The programme, the largest ever study of its kind, will study 5 million healthy people to develop new AI diagnostic tests. UCB, the global biopharmaceutical company, is investing around £1bn, with government investing £79m. The deal brings together 10 companies from across the sector. It is part of the government’s Life Science’s Sector Deal 2.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.